Search Results - "Pauli, Franziska Di"
-
1
Immunization status in patients with multiple sclerosis: A cross‐sectional, monocenter study in Austria
Published in European journal of neurology (01-05-2023)“…Background and purpose Patients with multiple sclerosis (MS) under certain disease‐modifying therapies (DMT) show a higher risk of infection and a lower immune…”
Get full text
Journal Article -
2
Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
Published in PloS one (08-07-2016)“…Multiple sclerosis (MS) has a highly heterogenic course making prediction of long term outcome very difficult. The objective was to evaluate current and…”
Get full text
Journal Article -
3
COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry
Published in PloS one (27-07-2021)“…Background The COVID-19 pandemic challenges neurologists in counselling patients with multiple sclerosis (pwMS) regarding their risk by SARS-CoV-2 and in…”
Get full text
Journal Article -
4
Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhage
Published in European journal of neurology (01-08-2023)“…Background and purpose Red blood cell (RBC) degradation after subarachnoid haemorrhage (SAH) negatively affects functional outcome. Although the detection of…”
Get full text
Journal Article -
5
Sexual dysfunction in female and male people with multiple sclerosis: disability, depression and hormonal status matter
Published in European journal of neurology (01-04-2023)“…Background and purpose Sexual dysfunction (SD) in people with multiple sclerosis (pwMS) is common and an often underestimated issue in the care of pwMS. The…”
Get full text
Journal Article -
6
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis
Published in European journal of neurology (01-04-2023)“…Background and purpose This study was undertaken to investigate baseline peripapillary retinal nerve fiber layer (pRNFL) and macular ganglion cell and inner…”
Get full text
Journal Article -
7
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Published in Journal of neuroinflammation (28-12-2011)“…Serum autoantibodies against the water channel aquaporin-4 (AQP4) are important diagnostic biomarkers and pathogenic factors for neuromyelitis optica (NMO)…”
Get full text
Journal Article -
8
Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study
Published in PloS one (20-03-2017)“…Risk of natalizumab-related progressive multifocal leukoencephalopathy is associated with the presence of anti-JC-virus (JCV) antibodies. To investigate the…”
Get full text
Journal Article -
9
Smelling multiple sclerosis: Different qualities of olfactory function reflect either inflammatory activity or neurodegeneration
Published in Multiple sclerosis (01-01-2020)“…Background: Peripapillary retinal nerve fiber layer (pRNFL) thickness and olfactory function are both emerging biomarkers in multiple sclerosis (MS)…”
Get full text
Journal Article -
10
Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years
Published in Scientific reports (02-12-2021)“…Natalizumab (NTZ) has been used for treatment of highly active relapsing–remitting multiple sclerosis (MS). When stopping NTZ the risk of severe rebound…”
Get full text
Journal Article -
11
Change of olfactory function as a marker of inflammatory activity and disability progression in MS
Published in Multiple sclerosis (01-02-2019)“…Background: Impaired olfactory threshold has been reported in early inflammatory phases of MS, while impaired odor identification was associated with more…”
Get full text
Journal Article -
12
Influence of physical activity on serum vitamin D levels in people with multiple sclerosis
Published in PloS one (11-06-2020)“…In most cases, multiple sclerosis (MS) patients reduce physical activity with disease progression and many patients are found to be vitamin D deficient. The…”
Get full text
Journal Article -
13
Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases
Published in Journal of the neurological sciences (15-05-2013)“…Abstract The aim of this observational study was to analyze clinical and immunological effects of rituximab treatment in neuromyelitis optica (NMO) and…”
Get full text
Journal Article -
14
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
Published in Frontiers in immunology (29-11-2018)“…Inflammatory demyelinating CNS syndromes include, besides their most common entity multiple sclerosis (MS), several different diseases of either monophasic or…”
Get full text
Journal Article -
15
Recovery of Chronic Inflammatory Demyelinating Polyneuropathy on Treatment With Ocrelizumab in a Patient With Co-Existing Multiple Sclerosis
Published in Journal of central nervous system disease (09-03-2022)“…The chimeric anti-CD20 antibody rituximab has demonstrated good efficacy as an off-label treatment in chronic inflammatory demyelinating polyneuropathy (CIDP),…”
Get full text
Journal Article -
16
The spectrum of MOG autoantibody-associated demyelinating diseases
Published in Nature reviews. Neurology (01-08-2013)“…In this Review, Reindl et al . discuss a range of CNS disorders that are known to be associated with autoantibodies against myelin oligodendrocyte glycoprotein…”
Get full text
Journal Article -
17
Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria
Published in Multiple sclerosis (01-01-2020)“…Background: Multiple sclerosis (MS) predominantly affects women of child-bearing potential. Pregnancy in MS is still a controversial issue lacking standardized…”
Get full text
Journal Article -
18
Multiple sclerosis and COVID‐19: How many are at risk?
Published in European journal of neurology (01-10-2021)“…Background and Purpose The coronavirus disease 2019 (COVID‐19) pandemic challenges neurologists in counseling multiple sclerosis (MS) patients with respect to…”
Get full text
Journal Article -
19
Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis
Published in Multiple sclerosis (01-02-2019)“…Background: Peripapillary retinal nerve fibre layer (pRNFL) thickness is emerging as a marker of axonal degeneration in multiple sclerosis (MS). Objective: We…”
Get full text
Journal Article -
20
Macular ganglion cell–inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis
Published in Multiple sclerosis (01-04-2021)“…Background: Macular ganglion cell–inner plexiform layer (mGCIPL) is an emerging biomarker of neuroaxonal degeneration in multiple sclerosis (MS). Objective: We…”
Get full text
Journal Article